Top

New Weight-loss Drug

July 28, 2012 by · Comments Off on New Weight-loss Drug 

Weight-loss Drug, A potential new weight-loss drug created by scientists may help people shed pounds and keep them off, researchers say. In the study, obese mice treated with the drug ate less, lost weight and experienced improved metabolic health, such as reduced insulin resistance, compared with obese mice not given the drug.

The drug appears to work by increasing the body’s sensitivity to leptin, a hormone that suppresses appetite. It’s thought that obese people become desensitized to leptin, meaning their bodies do not respond to it.

“By sensitizing the body to naturally occurring leptin, the new drug could not only promote weight loss, but also help maintain it,” said study researcher George Kunos, of the National Institute on Alcohol Abuse and Alcoholism.

Because the study was conducted in mice, it’s not clear whether the effects will translate to people. The researchers plan to start tests of the drug in people if it passes a safety test required by the National Institutes of Health, Kunos said.

Because obese people become desensitized to leptin, simply giving people supplements of the hormone does not promote weight loss, studies have shown. The desensitization process is thought to involve cannabinoid receptors – the same receptors that are activated by chemicals in marijuana.

Activating cannabinoid receptors is known to promote feelings of hunger in marijuana smokers, and blocking these receptors has been shown to cause weight loss. However, a previously developed weight- loss drug, called rimonabant, that blocked cannabinoid receptors also caused serious psychiatric side effects, including anxiety and depression. Rimonabant was sold in Europe beginning in 2006, but was taken off the market a few years later.

Weight-loss Drug

February 10, 2012 by · Comments Off on Weight-loss Drug 

Weight-loss Drug, Over the 33 years it was available on the market before the drug Mediator was withdrawn, somewhere between one and two thousand patients may have died from cardiovascular side effects.

A new study co-authored by the National Institute of Health and Medical Research (Inserm) probed the number of estimated hospitalizations and deaths linked to the weight-loss drug- known often by its generic name, benfluorex- estimating the total number of hospitalizations at around 3,100 and deaths at about 1,300, but Inserm concedes that number could be higher. Over three decades, the Mediator was used as an appetite suppressant- intended to control blood sugar in diabetic patients who were obese- but was often prescribed as a general weight-loss drug.

The French drug maker behind the weight-loss drug Mediator, Servier, is being investigated “on suspicion of dishonest practices and deception,” and the drug was pulled from the market in 2010 amid evidence it damaged heart valves and caused users to suffer pulmonary hypertension, potentially leading to heart failure. A related drug- fenfluramine, which was marketed as Pondimin, Ponderax and Adifax- was pulled from the market in the late 90?s after it was determined that there was a link between use of the medications and heart valve damage, and it was part of the controversial weight-loss drug combo Fen-Phen.

Bottom